Clinical Trial Update: Sirolimus for Massive Polycystic Liver [Phase 2, Phase 3]

View source ↗

Summary

This entry reports an update on a clinical trial of sirolimus for massive polycystic liver disease associated with polycystic kidney disease, spanning Phase 2 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Kidney Disease

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Polycystic Kidney Diseases | Phase 2, Phase 3 | Status: UNKNOWN